Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer

PURPOSE: To evaluate the feasibility of using skeletal muscle mass (SMM) at C3 (C3 SMM) as a diagnostic marker for sarcopenia in head and neck cancer (HNC) patients. METHODS: We evaluated 165 HNC patients and 42 healthy adults who underwent (18)F-fluorodeoxyglucose positron emission tomography/compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Joon-Kee, Jang, Jeon Yeob, An, Young-Sil, Lee, Su Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289025/
https://www.ncbi.nlm.nih.gov/pubmed/34280248
http://dx.doi.org/10.1371/journal.pone.0254844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289025/
https://www.ncbi.nlm.nih.gov/pubmed/34280248
http://dx.doi.org/10.1371/journal.pone.0254844

Ejemplares similares